Literature DB >> 3772153

Effect of essential fatty acid deficiency on cutaneous sterol synthesis.

K R Feingold, B E Brown, S R Lear, A H Moser, P M Elias.   

Abstract

The fact that the skin is a major site of total body sterologenesis, coupled both with the apparent absence of low density lipoprotein receptors on keratinocytes and with the lack of influence of serum cholesterol on epidermal sterologenesis, has created the impression that epidermal lipid synthesis might be autonomous, i.e., nonregulatable. Recent studies have shown, however, that disruption of cutaneous barrier function with acetone or detergents stimulates epidermal sterologenesis (J Lipid Res 26:418-427, 1985). To correlate further sterologenesis with barrier function, we measured de novo synthesis of cholesterol and total nonsaponifiable lipids in essential fatty acid-deficient (EFAD) hairless mice. Animals with defective barrier function, manifested by abnormal transepidermal water loss, demonstrated a 2-fold increase in epidermal cholesterol and total nonsaponifiable lipid synthesis over controls while synthesis in the dermis was unchanged. Epidermal sterologenesis in EFAD animals, repleted with linoleic acid either systematically or topically, returned toward normal as barrier function improved. Moreover, plastic occlusion of EFAD mouse skin normalized epidermal sterologenesis at 1 and 3 days. These results provide further evidence that epidermal sterologenesis is not entirely autonomous, and can be regulated by water barrier requirements.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3772153     DOI: 10.1111/1523-1747.ep12455835

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  11 in total

1.  Lipid composition of outer stratum corneum and nails in atopic and control subjects.

Authors:  B Melnik; J Hollmann; U Hofmann; M S Yuh; G Plewig
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

2.  Barrier function regulates epidermal DNA synthesis.

Authors:  E Proksch; K R Feingold; M Q Man; P M Elias
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

3.  Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice.

Authors:  L C Wood; S M Jackson; P M Elias; C Grunfeld; K R Feingold
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

4.  Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in murine epidermis. Modulation of enzyme content and activation state by barrier requirements.

Authors:  E Proksch; P M Elias; K R Feingold
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

5.  Content of the different lipid classes in psoriatic scale.

Authors:  S Motta; S Sesana; R Ghidoni; M Monti
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

6.  Cholesterol synthesis is required for cutaneous barrier function in mice.

Authors:  K R Feingold; M Q Man; G K Menon; S S Cho; B E Brown; P M Elias
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

7.  Stratum corneum lipids of human epidermal keratinocyte air-liquid cultures: implications for barrier function.

Authors:  A H Kennedy; G M Golden; C L Gay; R H Guy; M L Francoeur; V H Mak
Journal:  Pharm Res       Date:  1996-08       Impact factor: 4.200

8.  Localization of epidermal sphingolipid synthesis and serine palmitoyl transferase activity: alterations imposed by permeability barrier requirements.

Authors:  W M Holleran; W N Gao; K R Feingold; P M Elias
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

Review 9.  Pathobiology of the stratum corneum.

Authors:  S M Jackson; M L Williams; K R Feingold; P M Elias
Journal:  West J Med       Date:  1993-03

10.  Sphingolipids are required for mammalian epidermal barrier function. Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation.

Authors:  W M Holleran; M Q Man; W N Gao; G K Menon; P M Elias; K R Feingold
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.